This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Find the latest science, technology and partners in antibody engineering, immunobiology and next generation binders.

Podcast: How to Create the Ultimate Bispecific

Share this article

What does it take to create the perfect bispecific?

That's what we asked Volker Schellenberger, President and Chief Technology Officer at Amunix Pharmaceuticals in a very first episode of the Life Sciences podcast.

As co-founder of Amunix, Schellenberger is the lead inventor of the company’s XTEN as well as XPAT platforms of protease-activated T-cell engagers. In conversation with Conference Producer Eden Turner, he discussed the key steps to producing the ultimate bispecific, including the most important considerations for designing a platform and notable trends in antibody engineering techniques.

Listen to the full podcast episode below or click here to listen on Soundcloud.

Share this article

Upcoming event

Antibody Engineering & Therapeutics US

12 - 16 Dec 2021, Marriott Marquis San Diego
THE #1 ANTIBODY ENGINEERING CONFERENCE FOR ACCELERATING NEXT GENERATION ANTIBODIES TO COMMERCIAL SUCCESS
Go to site